Clinical Trials Directory

Trials / Completed

CompletedNCT00515593

PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)

Non-interventional Open Single Arm, Multicentre Study to Observe the Use of Preotact in Patients With Severe Postmenopausal Osteoporosis

Status
Completed
Phase
Study type
Observational
Enrollment
110 (actual)
Sponsor
Nycomed · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objectives of the study are * to describe the quality of life at the beginning of the Preotact® treatment and at the end of the observational period (Qualeffo-41 questionnaire) * pain assessment at the beginning of the Preotact® treatment and at the end of the observational period (VAS score) * to describe bone mineral density at the beginning of the Preotact® treatment and at the end of the observational period (T-Score) * to describe incidence of bone fractures caused by osteoporosis as well as of other pathological findings of the skeleton after the beginning of the Preotact® treatment * to describe serum level of calcium and the bone resorption marker desoxypyridinoline (DPD) and N- respectively C-terminal crosslink-telopeptide (CTX and NTX) at the beginning of the Preotact® treatment and at the end of the observational period (only in subgroup of patients, where the physician sees a need to measure these parameters) * to document all adverse drug reactions after the beginning of the Preotact® treatment * the analysis of subgroups with different risk for bone fractures caused by osteoporosis at the beginning of the Preotact® treatment * to assess the manageability and functioning of the Pen system for injection of Preotact® (self administered questionnaire)

Conditions

Interventions

TypeNameDescription
DRUGParathyroid hormone (PTH) (Preotact)Patients with severe postmenopausal osteoporosis

Timeline

Start date
2006-09-01
Completion
2008-07-01
First posted
2007-08-14
Last updated
2012-05-07

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00515593. Inclusion in this directory is not an endorsement.